{"id":"tp-43009","type":"article-newspaper","title":"FDA Clears United Therapeutics for Phase 1 Trial of PAH Candidate","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/43009","datePublished":"2026-10-28T22:16:26.000Z","dateModified":"2026-10-28T22:16:26.000Z","language":"en","abstract":"The open-label study will use a single ascending dose design in healthy participants and assess safety, tolerability and pharmacokinetics.","section":"Regulation","references":[]}